Express Scripts Holding Co (NASDAQ:ESRX) Quarterly Sentiment Change Reported at 0.69

May 16, 2018 - By Loretta Love

Express Scripts Holding Company (NASDAQ:ESRX) Corporate Logo

“Big money” Positions

“Big money sentiment for Express Scripts Holding Co (NASDAQ:ESRX) in 2017 Q4 increased to 0.69, according to SEC.gov filings. So its up 0.06, from 2017Q3’s 0.63. 324 active investment managers increased and started new positions, while 472 reduced and sold their stock positions in Express Scripts Holding Co so the sentiment is more positive. Funds own 479.26 million shares, down from 486.65 million shares in 2017Q3. Funds holding Express Scripts Holding Co in top 10 increased from 18 to 23 for an increase of 5. In total 68 funds closed positions, 404 reduced and 214 increased. Also 110 funds bought new Express Scripts Holding Co stakes.

Significant Express Scripts Holding Co Shareholders

Bloombergsen Inc. owns 2.65 million shares in Express Scripts Holding Co as of 2017 Q4. As of 2017 Q4, 3.55 million shares of Express Scripts Holding Co are owned by Green Valley Investors Llc. In addition, Cortland Associates Inc Mo reported 834,917 shares in Express Scripts Holding Co equivalent to 11.35% of its equity exposure. The New York-based fund Chieftain Capital Management Inc. have invested about 9.21% of the investment manager’s stock portfolio in Express Scripts Holding Co. The United Kingdom-based fund Cedar Rock Capital Ltd looks positive on Express Scripts Holding Co, possessing 4.88 million shares.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe.The firm is worth $41.42 billion. It operates in two divisions, PBM and Other Business Operations.9.53 is the P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

ESRX touched $73.73 during the last trading session after $0.49 change.Express Scripts Holding Company has volume of 1.32 million shares. Since May 16, 2017 ESRX has risen 8.93% and is uptrending. ESRX underperformed by 2.62% the S&P500.

Express Scripts Holding Company (NASDAQ:ESRX) is expected to announce earnings on July, 24., as reported by Faxor. The EPS diference is $0.51 or 29.48 % up from last years number. Previous year: $1.73; Analysts forcast: $2.24. If reported the P/E will be 8.23 with $1.26B profit. 26.55 % EPS growth is what Wall Street’s sees after $1.77 reported EPS last quarter.

New Mexico Educational Retirement Board accumulated 0.16% or 55,540 shs. Moreover, Cap Fund has 0.05% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 112,717 shs. Edge Wealth Management holds 0.02% or 988 shs. Cypress Gp holds 0.19% in Express Scripts Holding Company (NASDAQ:ESRX) or 12,363 shs. Swiss Retail Bank has 0.17% invested in Express Scripts Holding Company (NASDAQ:ESRX). Wms Partners Limited Liability Company reported 159,992 shs or 1.34% of all its holdings. Panagora Asset Inc reported 860,552 shs. Dubuque Natl Bank holds 550 shs. Rampart Invest Management Communication Ltd Llc invested 0.2% in Express Scripts Holding Company (NASDAQ:ESRX). Bradley Foster Sargent Ct holds 22,732 shs or 0.06% of its capital. Hedeker Wealth Ltd Liability reported 0.22% stake. Group Inc One Trading Limited Partnership owns 40 shs. Koch Industr has invested 0.18% in Express Scripts Holding Company (NASDAQ:ESRX). Rech And Mgmt Com invested in 0% or 83 shs. Moreover, Cetera Advisor Networks Ltd Liability Corporation has 0.03% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 8,772 shs.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

In total 16 analysts cover Express Scripts Holding (NASDAQ:ESRX). “Buy” rating has 5, “Sell” are 2, while 9 are “Hold”. (NASDAQ:ESRX) has 31% bullish analysts. 28 are the (NASDAQ:ESRX)’s ratings reports on 16 May 2018 according to StockzIntelligence Inc. In Thursday, May 3 report Leerink Swann maintained it with “Hold” rating and $8000 target. On Thursday, March 8 the stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Hold” rating given by William Blair. On Thursday, January 11 the firm earned “Buy” rating by SunTrust. On Wednesday, December 6 the stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Market Perform” rating by Bernstein. On Wednesday, December 20 the stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Buy” rating given by SunTrust. On Wednesday, January 24 Mizuho maintained the shares of ESRX in report with “Hold” rating. The stock rating was upgraded by RBC Capital Markets to “Outperform” on Wednesday, January 31. On Monday, March 12 the stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Market Perform” rating by Bernstein. On Thursday, May 3 Barclays Capital maintained Express Scripts Holding Company (NASDAQ:ESRX) with “Equal-Weight” rating. On Thursday, March 8 the rating was downgraded by Maxim Group to “Hold”.

For more Express Scripts Holding Company (NASDAQ:ESRX) news released recently go to: Prnewswire.com, Streetinsider.com, Nasdaq.com, Bizjournals.com or Gurufocus.com. The titles are as follows: “Inside Rx Prescription Savings Program Marks First Anniversary By Achieving $100 Million Savings Milestone” released on May 16, 2018, “ValueAct’s 13F Shows New Stake in SLM Corp (SLM), Confirms Increase in Citi (C), Exits Microsoft (MSFT) (more…)” on May 15, 2018, “Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck” with a publish date: May 11, 2018, “Moody’s likes the upward financial trend at this Lakeland pharmacy benefits manager” and the last “Merger Arbitrage Positions Dominate Seth Klarman’s Equity Portfolio” with publication date: May 16, 2018.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: